阿尼製藥 ANIP 深 滬
已收盤 06-12 16:00:00 美东时间
81.68
+0.030
+0.04%
華盛通- 最 高83.6598
- 今 開82.10
- 成交量 17.98万股
- 最 低 80.75
- 昨 收 81.65
- 總市值 18.58亿
- 52周最高 99.50
- 市盈率 靜 24.57
- 換手率 0.79%
- 52周最低 62.605
- 委 比 40.30%
- 總股本 2274.55万
- 歷史最高 99.50
- 量 比 0.69
- 振 幅 3.56%
- 歷史最低 0.80
- 每 手 1
- 風險率 9.20%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ANI Pharmaceuticals director Thomas Haughey disposes of 2,000 shares for $161,760
ANI Pharmaceuticals director Thomas Haughey disposes of 2,000 shares for $161,760 ANI Pharmaceuticals director Thomas Haughey received 4,357 restricted shares on May 21, 2026 at USD 0. Haughey sold 2,000 shares on June 8, 2026 at USD 80.88. He held 38,878 shares following the transactions. Disclaime
06-11 09:07
ANI Pharma CEO Lalwani to speak at Jefferies Global Healthcare Conference fireside chat
ANI Pharma CEO Lalwani to speak at Jefferies Global Healthcare Conference fireside chat ANI Pharmaceuticals CEO Nikhil Lalwani will join a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026. The session is scheduled for 3:45 p.m. ET. Disclaimer: This news brief was created b
05-27 18:50
ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
ANI Pharmaceuticals, Inc. announced that CEO Nikhil Lalwani will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 3:45 p.m. ET. The live and archived webcast will be available on the Company’s website under the Investors section, with the replay accessible for 90 days. ANI is a biopharmaceutical company focused on developing innovative therapeutics across rare diseases, generics, and...
05-27 10:50
ANI Pharmaceuticals Shareholders Approve Amended 2022 Incentive Plan
ANI Pharmaceuticals ( ($ANIP) ) just unveiled an update. ANI Pharmaceuticals, I...
05-22 04:31
财报速睇 | 阿尼制药 2026财年Q1营收2.37亿美元，同比增长20.5%；归母净利润0.12亿美元，同比增长390.7%
华盛资讯5月13日讯，阿尼制药公布2026财年Q1业绩，公司Q1营收2.37亿美元，同比增长20.5%，归母净利润0.12亿美元，同比增长390.7%。
05-13 20:47
ANI Pharmaceuticals Updates Investor Presentation, Highlights Non-GAAP Metrics
ANI Pharmaceuticals ( ($ANIP) ) has provided an update. On May 13, 2026, ANI Ph...
05-13 20:44
U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla May 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Airbnb, HII and Tesla on Monday. HIGHLIGHTS * Airbnb Inc ABNB.O : Jefferies raises target price to $175 from $165 - * ANI Ph
05-11 15:27
ANI Pharmaceuticals Q1 revenue rises 21%, adjusted EPS beats estimates
ANI Pharmaceuticals Q1 revenue rises 21%, adjusted EPS beats estimates Overview US biopharma firm's Q1 revenue rose 20.5%, beating analyst expectations Adjusted EPS for Q1 beat analyst expectations Company authorized $100 mln share repurchase program Outlook ANI Pharmaceuticals raises 2026 total net
05-08 18:59
ANI Pharmaceuticals Raises FY2026 Adj EPS Guidance from $8.83-$9.34 to $9.19-$9.69 vs $9.07 Est; Raises FY2026 Sales Guidance from $1.055B-$1.115B to $1.080B-$1.140B vs $1.050B Est.
ANI Pharmaceuticals (NASDAQ:ANIP) raises FY2026 Adj EPS guidance from $8.83-$9.34 to $9.19-$9.69 vs $9.07 analyst estimate. Raises FY2026 sales outlook from $1.055 billion-$1.115 billion to $1.080 billion-$1.140 billion
05-08 18:52
ANI Pharma Q1 FY26 net income rises 93.1% to USD 29.5 million; revenue increases 20.5% to USD 237.5 million
ANI Pharma Q1 FY26 net income rises 93.1% to USD 29.5 million; revenue increases 20.5% to USD 237.5 million ANI Pharmaceuticals Q1 net revenues rose 20.5% to USD 237.5 million. Net income available to common shareholders climbed to USD 29.5 million; diluted GAAP EPS increased to USD 1.28. Adjusted n
05-08 18:51
